Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- 最新申報
- 2026/8/14
2025 年第 1 季持倉
持倉截至 2025/3/31，2025/5/15 申報。只含多頭部位，變化是跟 2024 年第 4 季比股數。
- 持股檔數
- 112
- 較 2024 年第 4 季 +9
- 總值
- $4.05 億
- 較 2024 年第 4 季 −$1.36 億 (−25.1%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,572,181 | $2,416 萬 | 6.0% | +3,000+0.2% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,663,974 | $2,044 萬 | 5.0% | +282,733+20.5% | 加碼 | 歷史 |
| SNYSanofi | SPONSORED ADR | 304,515 | $1,689 萬 | 4.2% | −80,000−20.8% | 減碼 | 歷史 |
| NVMINova Ltd. | COM | 90,697 | $1,672 萬 | 4.1% | +22,551+33.1% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 175,060 | $1,287 萬 | 3.2% | −50,000−22.2% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 366,608 | $1,267 萬 | 3.1% | −538,671−59.5% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 157,931 | $1,008 萬 | 2.5% | +59,010+59.7% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 267,385 | $968.2 萬 | 2.4% | +38,609+16.9% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 11,690 | $965.5 萬 | 2.4% | −1,500−11.4% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 507,829 | $921.7 萬 | 2.3% | +33,726+7.1% | 加碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 52,831 | $876.1 萬 | 2.2% | −17,000−24.3% | 減碼 | 歷史 |
| NVONovo Nordisk A S | ADR | 118,080 | $819.9 萬 | 2.0% | +20,000+20.4% | 加碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 2,307,119 | $782.1 萬 | 1.9% | −244,500−9.6% | 減碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 465,526 | $739.3 萬 | 1.8% | +274,854+144.2% | 加碼 | 歷史 |
| AMZNAmazon Com Inc | Stock | 36,607 | $696.5 萬 | 1.7% | −26,000−41.5% | 減碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 30,256 | $633.9 萬 | 1.6% | −4,000−11.7% | 減碼 | 歷史 |
| PHVSPharvaris N.V. | COM | 383,856 | $602.7 萬 | 1.5% | −4,327−1.1% | 減碼 | 歷史 |
| ORAOrmat Technologies, Inc. | COM | 84,000 | $594.5 萬 | 1.5% | +5,000+6.3% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 144,961 | $582.6 萬 | 1.4% | −8,060−5.3% | 減碼 | 歷史 |
| METAMeta Platforms, Inc. | Stock | 9,962 | $574.2 萬 | 1.4% | −11,039−52.6% | 減碼 | 歷史 |
| NVSNovartis AG | ADR | 50,000 | $557.4 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| MRKMerck & Co., Inc. | Stock | 59,600 | $535.0 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 140,660 | $532.7 萬 | 1.3% | +49,077+53.6% | 加碼 | 歷史 |
| Ormat Technologies, Inc.686688AC6 | DEBT 2.500% 7/1 | 5,037,000 | $523.0 萬 | 1.3% | 00.0% | 不變 | – |
| NICENICE Ltd. | SPONSORED ADR | 33,303 | $513.4 萬 | 1.3% | −9,197−21.6% | 減碼 | 歷史 |
| GSKGSK plc | ADR | 130,000 | $503.6 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| SEDGSolaredge Technologies, Inc. | COM | 309,216 | $500.3 萬 | 1.2% | −65,784−17.5% | 減碼 | 歷史 |
| ETNB89bio, Inc. | COM | 618,343 | $449.5 萬 | 1.1% | +61,811+11.1% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 106,532 | $448.4 萬 | 1.1% | −24,000−18.4% | 減碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 921,111 | $415.4 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 181,346 | $396.6 萬 | 1.0% | −24,905−12.1% | 減碼 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 355,554 | $391.5 萬 | 1.0% | +355,554 | 新進 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 200,000 | $358.4 萬 | 0.9% | −20,700−9.4% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 1,284,151 | $355.7 萬 | 0.9% | +72,618+6.0% | 加碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 277,550 | $353.6 萬 | 0.9% | +80,000+40.5% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 329,262 | $344.4 萬 | 0.8% | +93,000+39.4% | 加碼 | 歷史 |
| ANNXAnnexon, Inc. | COM | 1,764,387 | $340.5 萬 | 0.8% | +521,348+41.9% | 加碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 125,840 | $339.8 萬 | 0.8% | +57,507+84.2% | 加碼 | 歷史 |
| HELPHelus Pharma Inc. | COM NEW | 527,222 | $334.3 萬 | 0.8% | −10,889−2.0% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 194,638 | $332.6 萬 | 0.8% | +194,638 | 新進 | 歷史 |
| NVDANVIDIA Corp | Stock | 29,605 | $320.9 萬 | 0.8% | +29,605 | 新進 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,081,447 | $313.6 萬 | 0.8% | −84,448−7.2% | 減碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 106,000 | $312.9 萬 | 0.8% | +106,000 | 新進 | – |
| AMGNAmgen Inc | Stock | 10,000 | $311.6 萬 | 0.8% | +10,000 | 新進 | 歷史 |
| BIIBBiogen Inc. | COM | 22,738 | $311.1 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ACOGAlpha Cognition Inc. | COM NEW | 596,992 | $302.1 萬 | 0.7% | −23,008−3.7% | 減碼 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,604,429 | $285.6 萬 | 0.7% | +102,000+6.8% | 加碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 381,080 | $270.9 萬 | 0.7% | −85,000−18.2% | 減碼 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 334,987 | $265.6 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| AMATApplied Materials Inc | Stock | 18,000 | $261.2 萬 | 0.6% | +18,000 | 新進 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 78,193 | $251.4 萬 | 0.6% | −12,000−13.3% | 減碼 | 歷史 |
| CRMSalesforce, Inc. | Stock | 9,100 | $244.2 萬 | 0.6% | +9,100 | 新進 | 歷史 |
| BHVNBiohaven Ltd. | COM | 99,784 | $239.9 萬 | 0.6% | −56,710−36.2% | 減碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 528,365 | $236.7 萬 | 0.6% | −31,635−5.6% | 減碼 | 歷史 |
| SKYESkye Bioscience, Inc. | COM NEW | 1,476,353 | $234.7 萬 | 0.6% | −88,275−5.6% | 減碼 | 歷史 |
| WDAYWorkday, Inc. | CL A | 10,000 | $233.5 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 52,009 | $229.5 萬 | 0.6% | −47,991−48.0% | 減碼 | 歷史 |
| PFEPfizer Inc | Stock | 90,000 | $228.1 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 343,522 | $226.7 萬 | 0.6% | −266,565−43.7% | 減碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 111,743 | $219.9 萬 | 0.5% | +111,743 | 新進 | 歷史 |
| TSEMTower Semiconductor Ltd | SHS NEW | 61,549 | $219.5 萬 | 0.5% | −104,600−63.0% | 減碼 | 歷史 |
| UBERUber Technologies, Inc | Stock | 30,000 | $218.6 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| GOOGAlphabet Inc. | Stock | 13,500 | $210.9 萬 | 0.5% | −30,000−69.0% | 減碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 83,270 | $201.1 萬 | 0.5% | −20,000−19.4% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 335,024 | $200.7 萬 | 0.5% | +335,024 | 新進 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM | 790,550 | $197.6 萬 | 0.5% | −18,000−2.2% | 減碼 | 歷史 |
| AVGOBroadcom Inc. | Stock | 11,695 | $195.8 萬 | 0.5% | −5,185−30.7% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 63,821 | $192.5 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NKENIKE, Inc. | Stock | 30,050 | $190.8 萬 | 0.5% | +30,050 | 新進 | 歷史 |
| CHKPCheck Point Software Technologies Ltd | ORD | 8,334 | $189.9 萬 | 0.5% | −27,301−76.6% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 271,792 | $181.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| MSFTMicrosoft Corp | Stock | 4,592 | $172.4 萬 | 0.4% | −17,735−79.4% | 減碼 | 歷史 |
| NTRNutrien Ltd. | COM | 30,894 | $153.5 萬 | 0.4% | −25,000−44.7% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 84,000 | $145.4 萬 | 0.4% | +84,000 | 新進 | 歷史 |
| WIXWix.com Ltd. | SHS | 8,800 | $143.8 萬 | 0.4% | −30,453−77.6% | 減碼 | 歷史 |
| FROGJFrog Ltd | Stock | 42,871 | $137.2 萬 | 0.3% | −147,510−77.5% | 減碼 | 歷史 |
| CAMTCamtek Ltd | ORD | 23,086 | $135.4 萬 | 0.3% | −13,201−36.4% | 減碼 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM | 1,929,297 | $134.2 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SHL Telemedicine Ltd78423T200 | ADS | 632,456 | $131.1 萬 | 0.3% | 00.0% | 不變 | – |
| ORICOric Pharmaceuticals, Inc. | COM | 234,834 | $131.0 萬 | 0.3% | −38,379−14.0% | 減碼 | 歷史 |
| CEVACeva Inc | COM | 48,920 | $125.3 萬 | 0.3% | +48,920 | 新進 | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 20,000 | $122.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 1,012,749 | $116.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NNDMNano Dimension Ltd. | SPONSORD ADS NEW | 717,518 | $114.1 萬 | 0.3% | +717,518 | 新進 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 1,191,140 | $108.4 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| OTLKOutlook Therapeutics, Inc. | Stock | 857,142 | $104.6 萬 | 0.3% | +857,142 | 新進 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 189,800 | $101.4 萬 | 0.2% | +50,000+35.8% | 加碼 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 900,428 | $98.1 萬 | 0.2% | −314,147−25.9% | 減碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 460,247 | $98.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MRVLMarvell Technology, Inc. | COM | 15,070 | $92.8 萬 | 0.2% | −63,541−80.8% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 125,000 | $87.8 萬 | 0.2% | +125,000 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 26,097 | $87.6 萬 | 0.2% | −26,000−49.9% | 減碼 | 歷史 |
| PERIPerion Network Ltd. | SHS NEW | 102,612 | $83.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM | 452,845 | $79.2 萬 | 0.2% | +452,845 | 新進 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 366,304 | $78.8 萬 | 0.2% | −89,300−19.6% | 減碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 205,859 | $65.5 萬 | 0.2% | −294,632−58.9% | 減碼 | 歷史 |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $60.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 90,855 | $58.9 萬 | 0.1% | −490,974−84.4% | 減碼 | 歷史 |
| APREAprea Therapeutics, Inc. | COM NEW | 270,000 | $55.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 421,229 | $54.3 萬 | 0.1% | −269,489−39.0% | 減碼 | 歷史 |
選擇權（3 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2024 年第 4 季之後清倉（9 檔）
2024 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 4 季股數 | 2024 年第 4 季市值 | 2024 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ACADAcadia Pharmaceuticals Inc | COM | 288,539 | $529.5 萬 | 1.0% | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 297,362 | $391.6 萬 | 0.7% | 歷史 |
| ENPHEnphase Energy, Inc. | Stock | 50,198 | $344.8 萬 | 0.6% | 歷史 |
| CRGXCARGO Therapeutics, Inc. | COM | 179,674 | $259.1 萬 | 0.5% | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 205,000 | $249.7 萬 | 0.5% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 690,272 | $98.7 萬 | 0.2% | 歷史 |
| ALMSAlumis Inc. | COM | 125,000 | $98.3 萬 | 0.2% | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 118,758 | $44.4 萬 | 0.1% | 歷史 |
| CGENCompugen Ltd | ORD | 177,094 | $27.1 萬 | 0.1% | 歷史 |